Skip to search formSkip to main contentSkip to account menu

LY 333328

Known as: LY-333328, LY333328 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

oritavancin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
United States Patent Lehoux
  • 2017
  • Corpus ID: 52840135
Boylan et al. Pharmacodynamics of Oritavancin (LY333328) in a Neutropenic-Mouse Thigh Model of Staphylococcus aureus Infec tion… 
2003
2003
Pharmacodynamics of Oritavancin ( LY 333328 ) in a Neutropenic-Mouse Thigh Model of Staphylococcus aureus Infection
The pharmacokinetics and pharmacodynamics of oritavancin (LY333328), a glycopeptide antibiotic with concentration-dependent… 
1998
1998
ANTIMICROBIAL SUSCEPTIBILITY STUDIES In Vitro Activity of LY333328 Against Vancomycin-Resistant Enterococci, Methicillin-Resistant Staphylococcus aureus, and Penicillin-Resistant Streptococcus…
We report the activity of LY333328 against 35 clinical isolates of vancomycin-resistant enterococci (including organisms carrying… 
1998
1998
Pharmacodynamics of LY333328 in a neutropenic mouse thigh model of Staphylococcus aureus infection
1998
1998
LY-333328 : GLYCOPEPTIDE ANTIBIOTIC
1997
1997
In-vitro susceptibility to LY333328 of vancomycin-resistant enterococci isolated from humans and animals.